Tudor Investment Corp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $373K | Buy |
+2,967
| New | +$373K | ﹤0.01% | 1350 |
|
2024
Q1 | – | Sell |
-3,574
| Closed | -$471K | – | 1787 |
|
2023
Q4 | $471K | Sell |
3,574
-45,245
| -93% | -$5.96M | ﹤0.01% | 1152 |
|
2023
Q3 | $5.49M | Buy |
+48,819
| New | +$5.49M | 0.06% | 342 |
|
2023
Q2 | – | Sell |
-5,016
| Closed | -$508K | – | 1827 |
|
2023
Q1 | $508K | Sell |
5,016
-43,036
| -90% | -$4.36M | 0.01% | 1134 |
|
2022
Q4 | $5.74M | Buy |
+48,052
| New | +$5.74M | 0.11% | 193 |
|
2022
Q3 | – | Sell |
-42,694
| Closed | -$4.16M | – | 1843 |
|
2022
Q2 | $4.16M | Buy |
42,694
+39,675
| +1,314% | +$3.87M | 0.11% | 213 |
|
2022
Q1 | $283K | Sell |
3,019
-41,521
| -93% | -$3.89M | 0.01% | 1297 |
|
2021
Q4 | $3.79M | Buy |
44,540
+15,028
| +51% | +$1.28M | 0.06% | 343 |
|
2021
Q3 | $2.83M | Buy |
29,512
+5,452
| +23% | +$523K | 0.05% | 432 |
|
2021
Q2 | $2.34M | Buy |
+24,060
| New | +$2.34M | 0.04% | 472 |
|
2021
Q1 | – | Sell |
-26,854
| Closed | -$2.57M | – | 1722 |
|
2020
Q4 | $2.57M | Sell |
26,854
-11,898
| -31% | -$1.14M | 0.07% | 319 |
|
2020
Q3 | $3.73M | Buy |
+38,752
| New | +$3.73M | 0.16% | 118 |
|
2020
Q1 | – | Sell |
-28,537
| Closed | -$3.07M | – | 1225 |
|
2019
Q4 | $3.07M | Buy |
28,537
+25,377
| +803% | +$2.73M | 0.14% | 167 |
|
2019
Q3 | $285K | Buy |
+3,160
| New | +$285K | 0.01% | 860 |
|
2019
Q2 | – | Sell |
-10,419
| Closed | -$918K | – | 1248 |
|
2019
Q1 | $918K | Sell |
10,419
-10,739
| -51% | -$946K | 0.04% | 488 |
|
2018
Q4 | $1.51M | Sell |
21,158
-2,000
| -9% | -$143K | 0.03% | 261 |
|
2018
Q3 | $2.85M | Buy |
+23,158
| New | +$2.85M | 0.07% | 177 |
|
2018
Q2 | – | Sell |
-8,941
| Closed | -$741K | – | 1149 |
|
2018
Q1 | $741K | Sell |
8,941
-19,927
| -69% | -$1.65M | 0.02% | 419 |
|
2017
Q4 | $2.24M | Buy |
+28,868
| New | +$2.24M | 0.06% | 141 |
|
2017
Q3 | – | Sell |
-5,428
| Closed | -$250K | – | 1185 |
|
2017
Q2 | $250K | Buy |
+5,428
| New | +$250K | 0.01% | 809 |
|
2015
Q2 | – | Sell |
-6,635
| Closed | -$263K | – | 1569 |
|
2015
Q1 | $263K | Buy |
+6,635
| New | +$263K | 0.01% | 1112 |
|
2013
Q4 | – | Sell |
-30,900
| Closed | -$350K | – | 1314 |
|
2013
Q3 | $350K | Buy |
+30,900
| New | +$350K | 0.01% | 504 |
|